GWAS |
- Breast cancer ( 29059683 23535729)
- Cellular nuclear factor (erythroid-derived 2)-like 2 levels ( 30767168)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Estimated glomerular filtration rate ( 31152163)
- Heel bone mineral density ( 30598549)
- Metabolite levels ( 23823483)
- Migraine ( 22683712 27322543)
- Migraine - clinic-based ( 23793025)
- Night sleep phenotypes ( 27126917)
- Postprandial triglyceride response ( 32603185)
- Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab) ( 25117820)
- Systolic blood pressure ( 30224653)
- Tonometry ( 17903302)
|
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cognitive function ( 25644384)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- Educational attainment ( 25201988)
- Metabolite levels ( 23823483)
- Response to cognitive-behavioural therapy in anxiety disorder ( 26989097)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Tourette syndrome ( 30818990)
|